Cloning, expression and functional characterization of the full-length murine ADAMTS13. |
| |
Authors: | K. BRUNO,D. V
LKEL,B. PLAIMAUER,G. ANTOINE,S. PABLE,D. G. MOTTO,H. L. LEMMERHIRT,F. DORNER,K. ZIMMERMANN,F. SCHEIFLINGER |
| |
Affiliation: | Baxter BioScience, Vienna, Austria. |
| |
Abstract: | ![]() Functional deficiency or absence of the human von Willebrand factor (VWF)-cleaving protease (VWF-cp), recently termed ADAMTS13, has been shown to cause acquired and congenital thrombotic thrombocytopenic purpura (TTP), respectively. As a first step towards developing a small animal model of TTP, we have cloned the complete (non-truncated) murine Adamts13 gene from BALB/c mice liver poly A+ mRNA. Murine ADAMTS13 is a 1426-amino-acid protein with a high homology and similar structural organization to the human ortholog. Transient expression of the murine Adamts13 cDNA in HEK 293 cells yielded a protein with a molecular weight of approximately 180 kDa which degraded recombinant murine VWF (rVWF) in a dose-dependent manner. The cleavage products of murine rVWF had the expected size of 140 and 170 kDa. Murine ADAMTS13 was inhibited by EDTA and the plasma from a TTP patient. |
| |
Keywords: | ADAMTS13 thrombotic thrombocytopenic purpura von Willebrand factor von Willebrand factor‐cleaving protease |
|
|